T1	CHEM 27 37	olmesartan
#1	AnnotatorNotes T1	C1098320; olmesartan; Organic Chemical · Pharmacologic Substance
T2	PROC 55 70	antropométricos
#2	AnnotatorNotes T2	C0003188; Anthropometry; Research Activity
T3	DISO 72 97	resistencia a la insulina
#3	AnnotatorNotes T3	C0021655; Insulin Resistance; Pathologic Function
T4	DISO 129 140	hipertensos
#4	AnnotatorNotes T4	C0020538; Hypertensive disease; Disease or Syndrome
T5	CHEM 332 343	telmisartan
#5	AnnotatorNotes T5	C0248719; telmisartan; Organic Chemical · Pharmacologic Substance
T6	CHEM 213 228	adipocitoquinas
#6	AnnotatorNotes T6	C1955907; Adipokines; Amino Acid, Peptide, or Protein · Biologically Active Substance
T7	CHEM 166 181	angiotensina II
#7	AnnotatorNotes T7	C0003009; angiotensin II; Amino Acid, Peptide, or Protein · Pharmacologic Substance · Biologically Active Substance
T8	PROC 316 327	tratamiento
#8	AnnotatorNotes T8	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T9	CHEM 351 361	olmesartan
#9	AnnotatorNotes T9	C1098320; olmesartan; Organic Chemical · Pharmacologic Substance
T10	DISO 375 381	obesos
#10	AnnotatorNotes T10	C0028754; Obesity; Disease or Syndrome
T11	PROC 289 311	parámetros bioquímicos
T12	DISO 450 462	hipertensión
#11	AnnotatorNotes T12	C0020538; Hypertensive disease; Disease or Syndrome
T13	DISO 481 489	obesidad
#12	AnnotatorNotes T13	C0028754; Obesity; Disease or Syndrome
T14	PROC 503 529	ensayo clínico randomizado
#13	AnnotatorNotes T14	C0206034; Clinical Trials, Randomized; Research Activity
T15	CHEM 605 615	olmesartan
#14	AnnotatorNotes T15	C1098320; olmesartan; Organic Chemical · Pharmacologic Substance
T16	PROC 771 778	glucosa
#15	AnnotatorNotes T16	C0337438; Glucose measurement; Laboratory Procedure
T17	PROC 1487 1491	HOMA
#16	AnnotatorNotes T17	C1829779; Homeostasis model assessment; Health Care Activity
T18	CHEM 790 800	colesterol
#17	AnnotatorNotes T18	C0008377; cholesterol; Organic Chemical · Biologically Active Substance
T19	PROC 839 852	triglicéridos
#18	AnnotatorNotes T19	C0202236; Triglycerides measurement; Laboratory Procedure
T20	PROC 868 875	leptina
#19	AnnotatorNotes T20	C1295176; Leptin measurement; Laboratory Procedure
T21	PROC 878 890	adiponectina
#20	AnnotatorNotes T21	C2700366; Adiponectin Measurement; Laboratory Procedure
T22	CHEM 1003 1010	glucosa
#21	AnnotatorNotes T22	C0017725; glucose; Organic Chemical · Biologically Active Substance · Pharmacologic Substance
T23	PROC 860 866	QUICKI
T24	CHEM 934 945	telmisartan
#22	AnnotatorNotes T24	C0248719; telmisartan; Organic Chemical · Pharmacologic Substance
T25	CHEM 1143 1153	olmesartan
#23	AnnotatorNotes T25	C1098320; olmesartan; Organic Chemical · Pharmacologic Substance
T26	PROC 1242 1256	LDL colesterol
#24	AnnotatorNotes T26	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T27	PROC 1298 1316	niveles de leptina
#25	AnnotatorNotes T27	C1295176; Leptin measurement; Laboratory Procedure
T28	CHEM 1309 1316	leptina
#26	AnnotatorNotes T28	C0299583; leptin; Amino Acid, Peptide, or Protein · Hormone
T29	CHEM 1416 1427	Telmisartan
#27	AnnotatorNotes T29	C0248719; telmisartan; Organic Chemical · Pharmacologic Substance
T30	PROC 1468 1475	glucosa
#28	AnnotatorNotes T30	C0337438; Glucose measurement; Laboratory Procedure
T31	PROC 1439 1466	niveles de presión arterial
#29	AnnotatorNotes T31	C0005824; Blood pressure determination; Health Care Activity
T32	PROC 1494 1501	leptina
#30	AnnotatorNotes T32	C1295176; Leptin measurement; Laboratory Procedure
T33	DISO 1515 1526	hipertensos
#31	AnnotatorNotes T33	C0020538; Hypertensive disease; Disease or Syndrome
T34	PROC 1557 1584	niveles de presión arterial
#32	AnnotatorNotes T34	C0005824; Blood pressure determination; Health Care Activity
T35	CHEM 1535 1545	Olmesartan
#33	AnnotatorNotes T35	C1098320; olmesartan; Organic Chemical · Pharmacologic Substance
T36	CHEM 1597 1605	lipídico
#34	AnnotatorNotes T36	C0023779; Lipids; Organic Chemical
T37	CHEM 89 97	insulina
#35	AnnotatorNotes T37	C0021641; Insulin; Amino Acid, Peptide, or Protein · Hormone · Pharmacologic Substance | C3537244; Insulins; Pharmacologic Substance
T38	PROC 728 751	índice de masa corporal
#36	AnnotatorNotes T38	C0005893; Body mass index procedure; Diagnostic Procedure | C3698309; Measurement of body mass index; Health Care Activity
T39	ANAT 743 751	corporal
#37	AnnotatorNotes T39	C0460148; Human body structure; Anatomical Structure | C1318419; Entire human body; Anatomical Structure
T40	ANAT 761 769	arterial
#38	AnnotatorNotes T40	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T41	PROC 780 788	insulina
#39	AnnotatorNotes T41	C0202098; Insulin measurement; Laboratory Procedure
T42	PROC 790 806	colesterol total
#40	AnnotatorNotes T42	C1445957; Serum total cholesterol measurement; Laboratory Procedure
T43	PROC 808 822	LDL-colesterol
#41	AnnotatorNotes T43	C0202117; Low density lipoprotein cholesterol measurement; Laboratory Procedure
T44	PROC 753 769	presión arterial
#42	AnnotatorNotes T44	C0005824; Blood pressure determination; Health Care Activity
T45	PROC 824 838	HDL-colesterol
#43	AnnotatorNotes T45	C0392885; High density lipoprotein measurement; Laboratory Procedure
T46	PROC 992 1010	niveles de glucosa
#44	AnnotatorNotes T46	C0337438; Glucose measurement; Laboratory Procedure
T47	PROC 854 858	HOMA
#45	AnnotatorNotes T47	C1829779; Homeostasis model assessment; Health Care Activity
T48	PROC 1043 1051	insulina
#46	AnnotatorNotes T48	C0202098; Insulin measurement; Laboratory Procedure
T49	PROC 1199 1209	colesterol
#47	AnnotatorNotes T49	C0201950; Cholesterol measurement test; Laboratory Procedure
T50	CHEM 1358 1369	telmisartan
#48	AnnotatorNotes T50	C0248719; telmisartan; Organic Chemical · Pharmacologic Substance
T51	PROC 1590 1605	perfil lipídico
#49	AnnotatorNotes T51	C0523744; Lipids measurement; Laboratory Procedure
T52	ANAT 1458 1466	arterial
#50	AnnotatorNotes T52	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T53	PROC 1477 1485	insulina
#51	AnnotatorNotes T53	C0202098; Insulin measurement; Laboratory Procedure
T54	ANAT 1576 1584	arterial
#52	AnnotatorNotes T54	C0003842; Arteries; Body Part, Organ, or Organ Component | C1285085; Entire artery; Body Part, Organ, or Organ Component
T55	CHEM 12 23	telmisartan
#53	AnnotatorNotes T55	C0248719; telmisartan; Organic Chemical · Pharmacologic Substance
T56	PROC 100 115	adipocitoquinas
#54	AnnotatorNotes T56	C4055489; Adipocytokine Assay; Laboratory Procedure
T57	PROC 552 564	randomizados
#55	AnnotatorNotes T57	C0034656; Randomization; Research Activity
T58	CHEM 579 590	telmisartan
#56	AnnotatorNotes T58	C0248719; telmisartan; Organic Chemical · Pharmacologic Substance
T59	PROC 1085 1089	HOMA
#57	AnnotatorNotes T59	C1829779; Homeostasis model assessment; Health Care Activity
T60	DISO 141 147	obesos
#58	AnnotatorNotes T60	C0028754; Obesity; Disease or Syndrome
T61	DISO 382 393	hipertensos
#59	AnnotatorNotes T61	C0020538; Hypertensive disease; Disease or Syndrome
T62	DISO 1527 1533	obesos
#60	AnnotatorNotes T62	C0028754; Obesity; Disease or Syndrome
T63	PROC 1130 1138	tratados
#61	AnnotatorNotes T63	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T64	LIVB 119 128	pacientes
#62	AnnotatorNotes T64	C0030705; Patients; Patient or Disabled Group
T67	LIVB 365 374	pacientes
#63	AnnotatorNotes T67	C0030705; Patients; Patient or Disabled Group
T68	LIVB 396 405	Pacientes
#64	AnnotatorNotes T68	C0030705; Patients; Patient or Disabled Group
T69	LIVB 436 445	pacientes
#65	AnnotatorNotes T69	C0030705; Patients; Patient or Disabled Group
T70	LIVB 535 544	pacientes
#66	AnnotatorNotes T70	C0030705; Patients; Patient or Disabled Group
T71	Dose 592 597	80 mg
T72	Frequency 597 601	/día
T73	Dose 617 622	40 mg
T74	Frequency 622 626	/día
T75	Duration 636 643	3 meses
T76	Duration 687 694	3 meses
T79	LIVB 909 918	pacientes
#67	AnnotatorNotes T79	C0030705; Patients; Patient or Disabled Group
T82	LIVB 1120 1129	pacientes
#68	AnnotatorNotes T82	C0030705; Patients; Patient or Disabled Group
T85	PHYS 1450 1466	presión arterial
#69	AnnotatorNotes T85	C0005823; Blood Pressure; Organism Function
T86	LIVB 1505 1514	pacientes
#70	AnnotatorNotes T86	C0030705; Patients; Patient or Disabled Group
T87	PHYS 1568 1584	presión arterial
#71	AnnotatorNotes T87	C0005823; Blood Pressure; Organism Function
T65	PROC 722 726	peso
#72	AnnotatorNotes T65	C2985231; Body Weight Measurement; Diagnostic Procedure
T66	Observation 1 8	Efectos
#73	AnnotatorNotes T66	C1518681; Outcome of Therapy; Finding (?)
R1	Causes Arg1:T55 Arg2:T66	
R2	Causes Arg1:T1 Arg2:T66	
T77	CONC 44 70	parámetros antropométricos
R3	Experiences Arg1:T64 Arg2:T4	
R4	Overlap Arg1:T4 Arg2:T60	
R5	Experiences Arg1:T64 Arg2:T60	
R6	Experiences Arg1:T64 Arg2:T3	
R7	Experiences Arg1:T64 Arg2:T2	
R8	Experiences Arg1:T64 Arg2:T1	
R9	Experiences Arg1:T64 Arg2:T55	
R10	Experiences Arg1:T64 Arg2:T66	
T78	Observation 276 282	efecto
#74	AnnotatorNotes T78	C1518681; Outcome of Therapy; Finding (?)
R11	Causes Arg1:T8 Arg2:T78	
R12	Used_for Arg1:T5 Arg2:T8	
R13	Used_for Arg1:T9 Arg2:T8	
R14	Experiences Arg1:T67 Arg2:T10	
R15	Experiences Arg1:T67 Arg2:T61	
R16	Overlap Arg1:T10 Arg2:T61	
R17	Experiences Arg1:T67 Arg2:T8	
R18	Experiences Arg1:T67 Arg2:T78	
R19	Experiences Arg1:T67 Arg2:T11	
R20	Experiences Arg1:T69 Arg2:T12	
R21	Overlap Arg1:T12 Arg2:T13	
R22	Experiences Arg1:T68 Arg2:T12	
R23	Experiences Arg1:T68 Arg2:T13	
T80	Quantifier_or_Qualifier 463 478	moderada severa
#75	AnnotatorNotes T80	C1299393; Moderate to severe; Qualitative Concept
R24	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T80	
R25	Before Arg1:T57 Arg2:T58	
R26	Before Arg1:T57 Arg2:T15	
R27	Has_Duration_or_Interval Arg1:T15 Arg2:T75	
R28	Has_Duration_or_Interval Arg1:T58 Arg2:T75	
R29	Experiences Arg1:T70 Arg2:T58	
R30	Experiences Arg1:T70 Arg2:T15	
R31	Has_Dose_or_Strength Arg1:T58 Arg2:T71	
R32	Has_Frequency Arg1:T58 Arg2:T72	
R33	Has_Dose_or_Strength Arg1:T15 Arg2:T73	
R34	Has_Frequency Arg1:T15 Arg2:T74	
T81	CONC 667 679	tiempo basal
#76	AnnotatorNotes T81	C3173566; Baseline time; Temporal Concept
R35	Overlap Arg1:T65 Arg2:T81	
R36	Overlap Arg1:T38 Arg2:T81	
R37	Location_of Arg1:T39 Arg2:T38	
R38	Location_of Arg1:T40 Arg2:T44	
R39	Overlap Arg1:T44 Arg2:T81	
R40	Overlap Arg1:T16 Arg2:T81	
R41	Overlap Arg1:T41 Arg2:T81	
R42	Overlap Arg1:T42 Arg2:T81	
R43	Overlap Arg1:T43 Arg2:T81	
R44	Overlap Arg1:T45 Arg2:T81	
R45	Overlap Arg1:T19 Arg2:T81	
R46	Overlap Arg1:T47 Arg2:T81	
R47	Overlap Arg1:T23 Arg2:T81	
R48	Overlap Arg1:T20 Arg2:T81	
R49	Overlap Arg1:T21 Arg2:T81	
R50	After Arg1:T65 Arg2:T76	
R51	After Arg1:T38 Arg2:T76	
R52	After Arg1:T44 Arg2:T76	
R53	After Arg1:T16 Arg2:T76	
R54	After Arg1:T41 Arg2:T76	
R55	After Arg1:T42 Arg2:T76	
R56	After Arg1:T43 Arg2:T76	
R57	After Arg1:T45 Arg2:T76	
R58	After Arg1:T19 Arg2:T76	
R59	After Arg1:T47 Arg2:T76	
R60	After Arg1:T23 Arg2:T76	
R61	After Arg1:T20 Arg2:T76	
R62	After Arg1:T21 Arg2:T76	
R63	Experiences Arg1:T79 Arg2:T24	
R64	Experiences Arg1:T79 Arg2:T46	
R65	Experiences Arg1:T79 Arg2:T48	
R66	Experiences Arg1:T79 Arg2:T59	
T83	Observation 959 970;985 1010	disminución de los niveles de glucosa
#77	AnnotatorNotes T83	C0017746; Decreased glucose level; Finding
T84	Observation 1043 1051;959 970;985 987	insulina disminución de
#78	AnnotatorNotes T84	C0854380; Blood insulin decreased; Finding (?)
R69	Experiences Arg1:T79 Arg2:T83	
R70	Experiences Arg1:T79 Arg2:T84	
T88	Observation 1085 1089;959 970;985 987	HOMA disminución de
R71	Experiences Arg1:T79 Arg2:T88	
R73	Experiences Arg1:T82 Arg2:T63	
R74	Used_for Arg1:T25 Arg2:T63	
R75	Experiences Arg1:T82 Arg2:T49	
R76	Experiences Arg1:T82 Arg2:T26	
T89	Observation 1170 1181;1196 1198;1242 1256	disminución de LDL colesterol
#79	AnnotatorNotes T89	C5232976; Reduced low-density lipoprotein cholesterol (LDL-C); Finding
R77	Experiences Arg1:T82 Arg2:T89	
T90	Observation 1170 1181;1196 1209	disminución de colesterol
#80	AnnotatorNotes T90	C4313076; Decreased cholesterol; Finding
R78	Experiences Arg1:T82 Arg2:T90	
R80	Causes Arg1:T24 Arg2:T83	
R81	Causes Arg1:T24 Arg2:T88	
R82	Causes Arg1:T24 Arg2:T84	
R83	Causes Arg1:T25 Arg2:T90	
R84	Causes Arg1:T25 Arg2:T89	
T91	Observation 1298 1329	niveles de leptina disminuyeron
#81	AnnotatorNotes T91	C5577912; Leptin level decreased; Finding 
R91	Causes Arg1:T50 Arg2:T91	
R92	Location_of Arg1:T52 Arg2:T85	
R93	Location_of Arg1:T52 Arg2:T31	
R94	Overlap Arg1:T33 Arg2:T62	
R95	Experiences Arg1:T86 Arg2:T33	
R96	Experiences Arg1:T86 Arg2:T62	
R97	Experiences Arg1:T86 Arg2:T32	
R98	Experiences Arg1:T86 Arg2:T17	
R99	Experiences Arg1:T86 Arg2:T53	
R100	Experiences Arg1:T86 Arg2:T30	
R101	Experiences Arg1:T86 Arg2:T31	
R102	Experiences Arg1:T86 Arg2:T85	
R103	Experiences Arg1:T86 Arg2:T29	
R112	Location_of Arg1:T54 Arg2:T87	
R113	Location_of Arg1:T54 Arg2:T34	
R116	Experiences Arg1:T64 Arg2:T56	
R79	Overlap Arg1:T3 Arg2:T4	
R104	Overlap Arg1:T3 Arg2:T60	
#82	AnnotatorNotes T11	C0430027; biochemical test; Laboratory Procedure (?)
#83	AnnotatorNotes T77	C0815129; anthropometric measurement; Quantitative Concept | C2598146; Anthropometric Measures; Intellectual Product
A1	Experiencer T86 Patient
A2	Experiencer T82 Patient
A3	Experiencer T79 Patient
A4	Experiencer T64 Patient
A5	Experiencer T67 Patient
A6	Experiencer T69 Patient
A7	Experiencer T68 Patient
A8	Experiencer T70 Patient
R67	Has_Result_or_Value Arg1:T46 Arg2:T83	
R68	Has_Result_or_Value Arg1:T48 Arg2:T84	
R72	Has_Result_or_Value Arg1:T59 Arg2:T88	
R85	Has_Result_or_Value Arg1:T49 Arg2:T90	
R86	Has_Result_or_Value Arg1:T26 Arg2:T89	
R87	Has_Result_or_Value Arg1:T27 Arg2:T91	
